Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Recruiting · NCT07050732 · Registry updated 2025-12-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons | Respiratory Syncytial Virus (RSV) | Recruiting | Phase 2 | 2025-12-12 | NCT07050732 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| Johns Hopkins University | 579 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 60 |